239 related articles for article (PubMed ID: 29111036)
21. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
[TBL] [Abstract][Full Text] [Related]
22. Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.
Martin DT; Steinbach JM; Liu J; Shimizu S; Kaimakliotis HZ; Wheeler MA; Hittelman AB; Mark Saltzman W; Weiss RM
Mol Cancer Ther; 2014 Jan; 13(1):71-81. PubMed ID: 24222663
[TBL] [Abstract][Full Text] [Related]
23. Silencing of the scavenger receptor (Class B - Type 1) gene using siRNA-loaded chitosan nanaoparticles in a HepG2 cell model.
Farid MM; Hathout RM; Fawzy M; Abou-Aisha K
Colloids Surf B Biointerfaces; 2014 Nov; 123():930-7. PubMed ID: 25466457
[TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
Song Y; Tang C; Yin C
Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
[TBL] [Abstract][Full Text] [Related]
25. The impact of the codelivery of drug-siRNA by trimethyl chitosan nanoparticles on the efficacy of chemotherapy for metastatic breast cancer cell line (MDA-MB-231).
Eivazy P; Atyabi F; Jadidi-Niaragh F; Aghebati Maleki L; Miahipour A; Abdolalizadeh J; Yousefi M
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):889-896. PubMed ID: 27188536
[TBL] [Abstract][Full Text] [Related]
26. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
Slütter B; Jiskoot W
J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
[TBL] [Abstract][Full Text] [Related]
27. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.
Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D
J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
29. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
[TBL] [Abstract][Full Text] [Related]
30. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
[TBL] [Abstract][Full Text] [Related]
31. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation.
Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S
J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554
[TBL] [Abstract][Full Text] [Related]
32. Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique.
Okuda T; Kito D; Oiwa A; Fukushima M; Hira D; Okamoto H
Biol Pharm Bull; 2013; 36(7):1183-91. PubMed ID: 23811567
[TBL] [Abstract][Full Text] [Related]
33. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
34. A study on the preparation of chitosan-tripolyphosphate nanoparticles and its entrapment mechanism for egg white derived peptides.
Du Z; Liu J; Zhang T; Yu Y; Zhang Y; Zhai J; Huang H; Wei S; Ding L; Liu B
Food Chem; 2019 Jul; 286():530-536. PubMed ID: 30827643
[TBL] [Abstract][Full Text] [Related]
35. Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology.
Xu PY; Kankala RK; Pan YJ; Yuan H; Wang SB; Chen AZ
Int J Nanomedicine; 2018; 13():4685-4698. PubMed ID: 30154654
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
37. Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.
Shali H; Shabani M; Pourgholi F; Hajivalili M; Aghebati-Maleki L; Jadidi-Niaragh F; Baradaran B; Movassaghpour Akbari AA; Younesi V; Yousefi M
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):293-302. PubMed ID: 28362176
[TBL] [Abstract][Full Text] [Related]
38. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
Han L; Tang C; Yin C
Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
[TBL] [Abstract][Full Text] [Related]
40. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
